Marie Alix Balay
Papers
1
Total Citations
4
H-Index
1
About
Marie Alix Balay is a pioneering endocrine surgeon whose work bridges the frontiers of minimally invasive oncology and nuclear medicine. Her primary research focuses on advanced surgical techniques for differentiated thyroid carcinoma, particularly transaxillary robotic thyroidectomy surgery (TARS). Dr. Balay made history with the first European study demonstrating the successful integration of TARS with postoperative radioiodine (RAI) therapy, proving that robotic surgery does not compromise oncological safety or the efficacy of subsequent nuclear medicine treatments. Her landmark 2018 paper, "Successful Treatment of Differentiated Thyroid Carcinoma with Transaxillary Robotic Surgery and Radioiodine," has garnered 4 citations and established a new standard for scarless, patient-centered thyroid cancer care. By validating that robotic approaches can achieve complete tumor resection while enabling effective RAI ablation, she has expanded treatment options for patients concerned about cosmetic outcomes. Dr. Balay’s work is instrumental in shaping protocols that combine surgical innovation with adjuvant therapies, offering a compelling path forward for personalized, less invasive management of thyroid malignancies. Her contributions continue to inspire surgeons and endocrinologists seeking to optimize both survival and quality of life.
Research Focus
Key Achievements
Top Papers
- 1